科学图书馆
-
Contemporary Presentation and Management of Valvular Heart Disease: The EURObservational Research Programme Valvular Heart Disease II SurveyB Iung , V Delgado ,the EORP VHD II Investigators. -
Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVRNM Van Mieghem, M Unverdorben, the ENVISAGE-TAVI AF Investigators.
-
Balloon Aortic Valvuloplasty as a Bridge to Aortic Valve Replacement: A Contemporary Nationwide PerspectiveA Kawsara, F Alqahtani, MF Eleid et al.
-
Thrombotic Versus Bleeding Risk After Transcatheter Aortic Valve Replacement: JACC Review Topic of the WeekA Mangieri, C Montalto, E Poletti et al.
-
Short Length of Stay After Elective Transfemoral Transcatheter Aortic Valve Replacement Is Not Associated With Increased Early or Late Readmission RiskM Sud , F Qui, PC Austin et al.
-
5-Year Outcomes After TAVR With Balloon-Expandable Versus Self-Expanding Valves: Results From the CHOICE Randomized Clinical TrialMohamed Abdel-Wahab, M Landt, Franz-Josef Neumann
-
Randomized Evaluation of TriGuard 3 Cerebral Embolic Protection After Transcatheter Aortic Valve Replacement: REFLECT IITM Nazif, J Moses, REFLECT II Trial Investigators et al.
-
Relationship Between Hospital Surgical Aortic Valve Replacement Volume and Transcatheter Aortic Valve Replacement OutcomesSA Hirji, E McCarthy, D Kim et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
